BiotechTube

BB-401

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Head and Neck Squamous Cell Carcinoma

Conditions

Head and Neck Squamous Cell Carcinoma

Trial Timeline

Mar 15, 2018 → Apr 6, 2020

NCT ID
NCT03433027

About BB-401

BB-401 is a phase 2 stage product being developed by Benitec Biopharma for Head and Neck Squamous Cell Carcinoma. The current trial status is completed. This product is registered under clinical trial identifier NCT03433027. Target conditions include Head and Neck Squamous Cell Carcinoma.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT03433027Phase 2Completed

Competing Products

20 competing products in Head and Neck Squamous Cell Carcinoma

See all competitors
ProductCompanyStageHype Score
AFM24 + SNK01AffimedPhase 1/2
33
Cemiplimab + CetuximabEli LillyPhase 2
52
Placebo + LY2300559Eli LillyPhase 2
52
Gemcitabine + ACR-368Acrivon TherapeuticsPhase 2
44
Ketorolac + Prochlorperazine + DiphenhydramineAssertio HoldingsPhase 2
44
Ramucirumab + PembrolizumabEli LillyPhase 2
52
Ozuriftamab Vedotin + Pembrolizumab + Evalstotug (BA3071) + CetuximabBioAtlaPhase 2
44
Patritumab + Cetuximab + Cisplatin + Carboplatin + PlaceboDaiichi SankyoPhase 2
52
Patritumab + Cetuximab + Cisplatin + CarboplatinDaiichi SankyoPhase 1
33
cevimeline hydrochlorideDaiichi SankyoPhase 3
77
Docetaxel + Erlotinib + ChemotherapyAstellas PharmaPhase 2
52
ErlotinibAstellas PharmaPhase 1
33
avelumab + Bempegaldesleukin + talazoparib + enzalutamideAstellas PharmaPhase 1/2
41
Ivermectin Lotion, 0.5% + SKLICE (ivermectin) Lotion, 0.5% + Vehicle of the Test productSun PharmaceuticalPhase 1
33
Drug Combination TherapySun PharmaceuticalPhase 2
52
Lenvatinib + Pembrolizumab + Docetaxel + Capecitabine + Paclitaxel + Cetuximab + LenvatinibEisaiPhase 2
52
E7050 + CetuximabEisaiPhase 1/2
41
Lenvatinib + Pembrolizumab + PlaceboEisaiPhase 3
77
Lenvatinib + Pembrolizumab + PlaceboEisaiPhase 3
77
Aricept (donepezil hydrochloride)EisaiPhase 2
52